These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11355593)

  • 1. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer. Report on 3-year tumour control and normal tissue toxicity.
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):207-8. PubMed ID: 11355593
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity.
    Skladowski K; Maciejewski B; Golen M; Pilecki B; Przeorek W; Tarnawski R
    Radiother Oncol; 2000 May; 55(2):101-10. PubMed ID: 10799721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
    Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
    Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
    Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
    Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
    Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
    Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic overview of radiation therapy effects in head and neck cancer.
    Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma.
    Horiot JC; Begg AC; Le Fur R; Schraub S; van den Bogaert W; van Glabbeke M; Pierart M
    Recent Results Cancer Res; 1994; 134():111-9. PubMed ID: 8153427
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Gemici C
    Lancet; 2004 Mar; 363(9413):992-3; author reply 993. PubMed ID: 15043975
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of head and neck radiotherapy reporting in randomized controlled trials.
    Tseng M; Tan TH; Zheng H; Soon YY; Tey J
    Head Neck; 2018 Aug; 40(8):1854-1860. PubMed ID: 29575476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.
    Coyle D; Drummond MF
    Clin Oncol (R Coll Radiol); 1997; 9(5):313-21. PubMed ID: 9368727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Vaupel P; Mayer A
    Lancet; 2004 Mar; 363(9413):992; author reply 993. PubMed ID: 15043976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.